| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348318 α-Amino-N-(diaminophosphinyl)lactam derivatives |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/25/2008 | CA2315835C New crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester |
| 03/25/2008 | CA2295455C Process for the preparation of mometasone furoate |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/25/2008 | CA2264822C Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/25/2008 | CA2228281C Use of l-carnitine and acyl l-carnitines for lowering ceramide levels |
| 03/25/2008 | CA2217679C Peptides and therapeutic agent for autoimmune diseases containing the same |
| 03/25/2008 | CA2189984C P75 tnf receptor promoters |
| 03/25/2008 | CA2174707C Chromone derivatives as nk1 and substance p antagonists |
| 03/25/2008 | CA2164642C Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 03/20/2008 | WO2008033854A1 Certain substituted amides, method of making, and method of use thereof |
| 03/20/2008 | WO2008033564A1 Compounds for modulating trpv3 function |
| 03/20/2008 | WO2008033460A2 Treating pain, diabetes, and lipid metabolism disorders |
| 03/20/2008 | WO2008033447A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | WO2008033069A1 Selective chemokine modulation |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032678A1 Adhesive preparation |
| 03/20/2008 | WO2008032665A1 Novel phenylacetic acid derivative |
| 03/20/2008 | WO2008032171A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 03/20/2008 | WO2008031875A1 Adenosine derivatives as a2a receptor agonists |
| 03/20/2008 | WO2008031788A1 Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase |
| 03/20/2008 | WO2008031221A1 Isovaline for treatment of pain |
| 03/20/2008 | WO2008016661A3 Morpholino compounds for treating inflammatory and demyelinating diseases and cancers |
| 03/20/2008 | WO2008013822A3 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 03/20/2008 | WO2008011478A3 Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 03/20/2008 | WO2007146087A3 SUBSTITUTED PYRAZOLO [1,5-α] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE |
| 03/20/2008 | WO2007068462A3 Mtor inhibitors for the treatment of inflammatory bowel disease |
| 03/20/2008 | WO2006094187A3 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/20/2008 | US20080071233 Pharmaceutical compositions |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070972 for an oral cytokine inhibitor of interleukin-1 beta converting enzyme; antiinflammatory agent: rheumatoid arthritis and psoriasis; wet granulated compound with the organic solvent, a first and second binding agent, porous agent, glidant, lubricant |
| 03/20/2008 | US20080070969 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/20/2008 | US20080070968 1-(4-fluoro-phenyl)-8-(4-methyl-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid (1,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amide; antidepressant, anxiolytic; nervous system disorders, metabolic disorders, obesity |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070961 storage stability; precipitation |
| 03/20/2008 | US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide |
| 03/20/2008 | US20080070941 Derivatives of n-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070929 Thiazoline and oxazoline derivatives and their methods of use |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070912 Phosphodiesterase inhibitors; neuropathic pain, inflammation, opioid dependence or withdrawal; 2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one for example |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070908 Compositions including antibiotics and methods for using same |
| 03/20/2008 | US20080070897 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component (ethanol) , a surfactant such as polyglycerol, polyoxyethylene castor oil |
| 03/20/2008 | US20080070880 Specific glucocorticosteroid compound having anti-inflammatory activity |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080070843 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 03/20/2008 | US20080070836 Zinc transporter LIV1 can be used as an epithelial-mesenchymal transition (EMT) regulatory agent; further, because EMT is involved in cancer progression, LIV1 antisense nucleotides and the like may be used as pharmaceuticals for treating cancer |
| 03/20/2008 | US20080070298 Promoter of Synoviolin Gene |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080069888 Modified release formulations of at least one form of tramadol |
| 03/20/2008 | US20080069846 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds |
| 03/20/2008 | US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2 |
| 03/20/2008 | US20080069815 Autoimmune diseases; rheumatic arthritis |
| 03/20/2008 | US20080069797 Rapamycin and il-10 for the treatment of immune diseases |
| 03/20/2008 | DE69717831C5 Substituierte 2-(2,6-dioxopiperidin-3-yl)-phthalimide und -1-oxoisoindoline und verfahren zur reduzierung des tnf-alpha-spiegels Substituted 2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindoline and -phthalimides and method for reducing the TNF-alpha levels |
| 03/20/2008 | DE102006030479A1 Indazolderivate Indazole derivatives |
| 03/20/2008 | CA2664251A1 Isovaline for treatment of pain |
| 03/20/2008 | CA2663947A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | CA2663501A1 Treating pain, diabetes, and disorders of lipid metabolism |
| 03/20/2008 | CA2663259A1 Selective chemokine modulation |
| 03/20/2008 | CA2663234A1 Novel phenylacetic acid derivative |
| 03/20/2008 | CA2663178A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 03/20/2008 | CA2662104A1 Adenosine derivatives as a2a receptor agonists |
| 03/20/2008 | CA2661654A1 Certain substituted amides, method of making, and method of use thereof |
| 03/19/2008 | EP1900739A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/19/2008 | EP1900738A2 Substituted pyrroline kinase inhibitors |
| 03/19/2008 | EP1900365A2 New endocannabinoid-like compounds and their use |
| 03/19/2008 | EP1900363A1 Therapeutic agent for pain |
| 03/19/2008 | EP1899480A1 Compositions and methods for treating inflammatory conditions |
| 03/19/2008 | EP1899330A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 03/19/2008 | EP1899011A1 Alpha-2 adrenergic agonists for the treatment of pain |
| 03/19/2008 | EP1898955A2 Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs |
| 03/19/2008 | EP1898930A2 Treatment of inflammatory conditions |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1392271B1 Swallow tablet comprising paracetamol |
| 03/19/2008 | EP1326980B1 Methods of treatment using wisp polypeptides |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | CN201036588Y Electric heating fumigating blanket |
| 03/19/2008 | CN101146798A Novel heterocyclic benzo[C]chromene derivatives useful as modulators of the estrogen receptors |
| 03/19/2008 | CN101146797A 4-2-(cycloalkylamino)pyrimidin-4-YL!- (phenyl)- imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |
| 03/19/2008 | CN101146793A Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity |
| 03/19/2008 | CN101146773A 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 03/19/2008 | CN101146544A Use of lactobacillus rhamnosus gg for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant |
| 03/19/2008 | CN101146525A Use of lactobacillus rhamnosus gg in combination with a long chain polyunsaturated fatty acid for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant |